Histone deacetylase inhibitors suppress
β
William Fazzone; Peter M. Wilson; Melissa J. LaBonte; Heinz-Josef Lenz; Robert D
π
Article
π
2009
π
John Wiley and Sons
π
French
β 532 KB
## Abstract Despite recent therapeutic advances, the response rates to chemotherapy for patients with metastatic colon cancer remain at βΌ50% with the fluoropyrimidine, 5βfluorouracil (5βFU), continuing to serve as the foundation chemotherapeutic agent for the treatment of this disease. Previous stu